Promise of human induced pluripotent stem cells in skin regeneration and investigation

Journal of Investigative Dermatology

Volumn 134, Issue 3, 2014, Pages 605-609

  Ohyama, Manabu ^a   Okano, Hideyuki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

GENODERMATOSES; HUMAN; KERATINOCYTE; NONHUMAN; ONCOGENE C MYC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATION; REVIEW; SKIN; SKIN DISEASE; SKIN FIBROBLAST; SKIN REGENERATION; STEM CELL TRANSPLANTATION; CELL THERAPY; GENODERMATOSIS; MEDICAL RESEARCH; MEDICINE; PATHOPHYSIOLOGY; PLASTICITY; SKIN APPENDAGE;

DERMATOLOGY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; REGENERATION; SKIN DISEASES; STEM CELL TRANSPLANTATION;

EID: 84894062963     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.376     Document Type: Article

References (40)

1. Aasen T, Raya A, Barrero MJ et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26:1276-844
2. Almaani N, Nagy N, Liu L et al. (2010) Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 130:1937-400
3. Amabile G, Welner RS, Nombela-Arrieta C et al. (2013) In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121:1255-644
4. Barrandon Y, Green H (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302-66
5. Blanpain C, Fuchs E (2009) Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10:207-177
6. Carey BW, Markoulaki S, Hanna J et al. (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA 106:157-622
7. Chino T, Tamai K, Yamazaki T et al. (2008) Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol 173:803-144
8. Cotsarelis G (2006) Epithelial stem cells: a folliculocentric view. J Invest Dermatol 126: 1459-688
9. Fujita Y, Abe R, Inokuma D et al. (2010) Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice. Proc Natl Acad Sci USA 107:14345-500
10. Green H, Kehinde O, Thomas J (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 76:5665-88
11. Harding J, Roberts RM, Mirochnitchenko O (2013) Large animal models for stem cell therapy. Stem Cell Res Ther 4:233
12. Higgins CA, Itoh M, Inoue K et al. (2012) Reprogramming of human hair follicle dermal papilla cells into induced pluripotent stem cells. J Invest Dermatol 132:1725-77
13. Imaizumi Y, Okada Y, Akamatsu W et al. (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:355
14. Itoh M, Kiuru M, Cairo MS et al. (2011) Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 108:8797-8022
15. Jahoda CA, Whitehouse J, Reynolds AJ et al. (2003) Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol 12:849-599
16. Jensen KB, Watt FM (2006) Single-cell expression profiling of human epidermal stem and transit- amplifying cells: Lrig1 is a regulator of stem cell quiescence. Proc Natl Acad Sci USA 103:11958-633
17. Kattman SJ, Witty AD, Gagliardi M et al. (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8:228-400
18. Kobayashi Y, Okada Y, Itakura G et al. (2012) Preevaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 7:e527877
19. Konig A, Bruckner-Tuderman L (1994) Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model. Lab Invest 70:203-99
20. Kuroda Y, Kitada M, Wakao S et al. (2010) Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107:8639-433
21. Li A, Simmons PJ, Kaur P (1998) Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA 95:3902-77
22. Mavilio F, Pellegrini G, Ferrari S et al. (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12:1397-4022
23. Miura K, Okada Y, Aoi T et al. (2009) Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 27:743-55
24. Nakamura M, Okano H (2013) Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells. Cell Res 23:70-800
25. Nori S, Okada Y, Yasuda A et al. (2011) Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 108:16825-300
26. Ohta S, Imaizumi Y, Okada Y et al. (2011) Generation of human melanocytes from induced pluripotent stem cells. PLoS One 6:e161822
27. Ohyama M, Terunuma A, Tock CL et al. (2006) Characterization and isolation of stem cellenriched human hair follicle bulge cells. J Clin Invest 116:249-600
28. Ohyama M, Veraitch O (2013) Strategies to enhance epithelial-mesenchymal interactions for human hair follicle bioengineering. J Dermatol Sci 70:78-877
29. Okano H, Nakamura M, Yoshida K et al. (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523-333
30. Pasmooij AM, Garcia M, Escamez MJ et al. (2010) Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 130:2407-111
31. Pellegrini G, Ranno R, Stracuzzi G et al. (1999) The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 68:868-799
32. Takahashi K, Tanabe K, Ohnuki M et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-722
33. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-766
34. Tolar J, Xia L, Riddle MJ et al. (2011) Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131:848-566
35. Toma JG, McKenzie IA, Bagli D et al. (2005) Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23:727-377
36. Tsai SY, Bouwman BA, Ang YS et al. (2011) Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells 29:964-711
37. Tsuji O, Miura K, Okada Y et al. (2010) Therapeutic effect of the appropriatelly evaluated 'safe' iPS cells for spinal cord injury. Proc Natl Acad Sci USA 107:12704-99
38. Uitto J (2011) Regenerative medicine for skin diseases: iPS cells to the rescue. J Invest Dermatol 131:812-44
39. Utikal J, Maherali N, Kulalert W et al. (2009) Sox22 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122:3502-100
40. Veraitch O, Kobayashi T, Imaizumi Y et al. (2013) Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo. J Invest Dermatol 133:1479-888